In this series of Translational Lung Cancer Research, a group of renowned world experts presents the comprehensive and timely review of state-of-the-art radiation therapy in lung cancer and other thoracic malignancies.
Editorial on Radiotherapy in Thoracic Malignancies
Radiotherapy in thoracic malignancies: the preface
Review Article on Radiotherapy in Thoracic Malignancies
Stereotactic radiotherapy for early stage non-small cell lung cancer: current standards and ongoing research
Preoperative and postoperative radiotherapy (RT) for non-small cell lung cancer: still an open question
Original Article on Radiotherapy in Thoracic Malignancies
Stage III N2 non-small cell lung cancer treatment: decision-making among surgeons and radiation oncologists
Review Article on Radiotherapy in Thoracic Malignancies
Dose and fractionation schedules in radiotherapy for non-small cell lung cancer
Challenges in the target volume definition of lung cancer radiotherapy
Evolving target volume concepts in locally advanced non-small cell lung cancer
Tumour motion management in lung cancer: a narrative review
Concurrent chemoradiotherapy for stage III non-small-cell lung cancer: recent progress and future perspectives (a narrative review)
Combining radiotherapy with targeted therapies in non-small cell lung cancer: focus on anti-EGFR, anti-ALK and anti-angiogenic agents
An overview of the published and running randomized phase 3 clinical results of radiotherapy in combination with immunotherapy
Thoracic radiotherapy in small cell lung cancer—a narrative review
Prophylactic cranial irradiation in SCLC
Controversies in the role of radiotherapy in pleural mesothelioma
Radiotherapy for thymic epithelial tumours: a review
Disclosure:
The series “Radiotherapy in thoracic malignancies” was commissioned by the editorial office, Translational Lung Cancer Research without any sponsorship or funding. Jacek Jassem and Rafał Dziadziuszko served as the unpaid Guest Editors for the series.